{"id":"NCT00413049","sponsor":"Novartis","briefTitle":"Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension","officialTitle":"A Multi-national, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel Study Comparing the Efficacy and Safety of Valsartan/Amlodipine 80/5 mg to Amlodipine 5 mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Amlodipine 5 mg Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-01","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2006-12-19","resultsPosted":"2011-02-08","lastUpdate":"2011-04-29"},"enrollment":698,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Valsartan/amlodipine 80/5 mg","otherNames":[]},{"type":"DRUG","name":"Amlodipine 5 mg","otherNames":[]}],"arms":[{"label":"Valsartan/amlodipine 80/5 mg","type":"EXPERIMENTAL"},{"label":"Amlodipine 5 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This study will evaluate the safety and efficacy of the fixed combination of valsartan/amlodipine in adult patients with mild to moderate hypertension","primaryOutcome":{"measure":"Change in Mean Sitting Diastolic Blood Pressure (msDBP) From Baseline to End of Study (Week 8)","timeFrame":"Baseline to end of study (Week 8)","effectByArm":[{"arm":"Valsartan/Amlodipine 80/5 mg","deltaMin":-9.7,"sd":0.42},{"arm":"Amlodipine 5 mg","deltaMin":-7.1,"sd":0.42}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":33},"locations":{"siteCount":12,"countries":["China"]},"refs":{"pmids":["20469975"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":349},"commonTop":[]}}